Liquidia (LQDA) Stock News
$LQDA · NASDAQ · 3 stories in 30 days$34.19
1D −1.70%1W +3.47%1M −58.95%
BORSA has published 3 stories on Liquidia (LQDA) in the past 30 days, 2 of them high impact. BORSA’s news read on LQDA is bullish at 66/100, unchanged over 24 hours, based on 1 company event over the past 7 days. LQDA last closed at $26.81 on Oct 13, up 3.47% over five sessions and down 58.95% over the past month. Liquidia’s next earnings report is scheduled for Monday, Nov 2.
The wire on $LQDA
newest first · updated · direct subject stories onlyLiquidia reaches global settlement with United Therapeutics
Liquidia announced a global settlement resolving all pending litigation with United Therapeutics.
bullish 65 · impact 40Liquidia shares fall 57% after court ruling on Yutrepia patent infringement
A court found two claims of United Therapeutics' '327 patent valid and infringed by Liquidia's Yutrepia. The PH-ILD indication faces possible removal. Liquidia will appeal. Shares fell roughly 57%.
bearish 25 · impact 75
